Clinical Trials For Genital Herpes Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients (CTNG)

Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients (CTNG)

This study is currently recruiting participants.

Verified by University Hospital Inselspital, Berne, September 2009

First Received: September 4, 2009   Last Updated: September 7, 2009   History of Changes

Sponsor:

University Hospital Inselspital, Berne

Collaborators:

Pfizer

Merck

Information provided by:

University Hospital Inselspital, Berne

ClinicalTrials.gov Identifier:

NCT00973466

Purpose

There has been an increase in incidence in sexually transmitted infections in HIV infected patients in the last years. In this study the investigators will prospectively evaluate the prevalence of symptomatic and asymptomatic infections with N. gonorrhea and Ch. trachomatis as well as the seroprevalence of Herpes simplex Type 2 infection in HIV-infected patients attending the clinic for infectious diseases at the Berne University Hospital. In addition, participants will be asked to fill out a questionnaire on sexual behaviour and sexual health.

Study hypothesis: STI prevalence is high in certain risk-groups to justify screening in regular intervals.


Condition

HIV Infections

Neisseria Gonorrhoeae

Chlamydia Trachomatis

Herpes Simplex


Study Type:

Observational

Study Design:

Observational Model: Cohort

Time Perspective: Prospective

Official Title:

Prevalence of Asymptomatic and Symptomatic Infection of N. Gonorrheae and C. Trachomatis and Seroprevalence of HSV Typ 2 and Sexual Health Seeking Behaviour in People With HIV Infection in Bern


Resource links provided by NLM:


MedlinePlus related topics: AIDS Chlamydia Infections Gonorrhea Herpes Simplex Sexually Transmitted Diseases

U.S. FDA Resources


Further study details as provided by University Hospital Inselspital, Berne:


Primary Outcome Measures:

Prevalence of infection with C.trachomatis, N. gonorrhea and Seroprevalence of HSV 2 infection [ Time Frame: 6 months ] [ Designated as safety issue: No ]


Estimated Enrollment:

300

Study Start Date:

May 2009

Estimated Study Completion Date:

August 2010

Estimated Primary Completion Date:

December 2009 (Final data collection date for primary outcome measure)

Groups/Cohorts

HIV-infection

All HIV-infected patients attending the Clinic for Infectious Diseases at Berne university hospital, having been sexually active during the past 12 months and having given written informed consent


Eligibility


Ages Eligible for Study:

18 Years and older

Genders Eligible for Study:

Both

Accepts Healthy Volunteers:

No

Sampling Method:

Probability Sample

Study Population

All consecutive HIV-infected patients attending the Clinic for Infectious Diseases at Bern University Hospital will be asked to participate in the study if they were sexually active during the last 12 months

Criteria

Inclusion Criteria:

HIV-infection

Attending the Clinic for Infectious Diseases from May 09 to November 09

Sexually active during the last 12 months

Written informed consent

Exclusion Criteria:

None

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00973466


Contacts

Contact: Hansjakob Furrer, MD

+41316322745

hansjakob.furrer@insel.ch


Locations

Switzerland

Clinic for Infectious Diseases, Berne University Hospital

Recruiting

Bern, Switzerland, 3010

Sub-Investigator: Katharina Sprenger, MD

Sponsors and Collaborators

University Hospital Inselspital, Berne

Pfizer

Merck

Investigators

Principal Investigator:

Hansjakob Furrer, MD

University Hospital Berne

More Information


No publications provided


Responsible Party:

University Hospital Inselspital, Berne ( Hansjakob Furrer, Leitender Arzt )

ClinicalTrials.gov Identifier:

NCT00973466 History of Changes

Other Study ID Numbers:

KEK26/09

Study First Received:

September 4, 2009

Last Updated:

September 7, 2009

Health Authority:

Switzerland: Ethikkommission


Keywords provided by University Hospital Inselspital, Berne:

HIV-infection

Neisseria gonorrhea

Chlamydia trachomatis

Herpes simplex virus

prevalence


Additional relevant MeSH terms:

Bacterial Infections

Sexually Transmitted Diseases, Bacterial

Sexually Transmitted Diseases, Viral

Slow Virus Diseases

Infection

Gram-Negative Bacterial Infections

Genital Diseases, Female

Chlamydiaceae Infections

Chlamydia Infections

Retroviridae Infections

Neisseriaceae Infections

Herpes Simplex

RNA Virus Infections

Skin Diseases

Immune System Diseases

Acquired Immunodeficiency Syndrome

Genital Diseases, Male

Immunologic Deficiency Syndromes

Herpesviridae Infections

Virus Diseases

Skin Diseases, Viral

Skin Diseases, Infectious

HIV Infections

Sexually Transmitted Diseases

Lentivirus Infections

Gonorrhea

DNA Virus Infections


ClinicalTrials.gov processed this record on June 15, 2010